Navigation Links
A New Option for Patients Suffering From QT Syndrome

Long QT syndrome is a disorder of the heart’s electrical system, which can be inherited or acquired. The syndrome’s name comes from // an elongated QT interval on an electrocardiogram. People with LQTS are prone to develop an extremely rapid heart rhythm, often brought on by exercise, emotion or loud noise. This improper rhythm interferes with blood flow to the brain and can result in fainting or cardiac arrest. A new study shows a specific surgery can reduce the risk of fainting or sudden death in people with a disorder called long QT syndrome.

Beta-blockers can also slow the heartbeat and prevent arrhythmias in LQTS patients. However, about a fourth of patients continue to experience symptoms while on the medication.

One current treatment method involves an implanted defibrillator that automatically delivers a shock to the heart with an irregular rhythm to return the rhythm to normal. Though researchers say this is the best protection, some patients experience storms of cardiac arrest resulting in multiple shocks. This can be frightening and interfere with quality of life.

The new alternative is a 40-minute surgery called left cardiac sympathetic denervation. The procedure reduces the heart’s control from the sympathetic nervous system by removing part of the nerves leading to the heart. The sympathetic nervous system is responsible for involuntary biological functions such as breathing and heart rate.

Based of the study results,of 147 patients, researchers found surgery reduced fainting and cardiac arrest by 91 percent, even in a population of patients at an especially high risk.
'"/>




Page: 1

Related medicine news :

1. Surprising Cystic Fibrosis Finding That Could Be A Helpful Treatment Option
2. New Treatment Option for Colorectal Cancer
3. Aspirin Not The Ideal Treatment Option For Stroke Patients
4. Better Treatment Options For Osteoporosis
5. New Treatment Option For Menstrual Migraine
6. The Options For Relieving Chest Pain In the Elderly Questioned
7. Treatment Options For Retinitis Pigmentosa Questioned
8. Another Treatment Option for Benign Tumors
9. The Latest Preventative Treatment Option for Prostate Cancer
10. Yet Another Treatment Option For Cancer
11. Acupuncture An Effective Treatment Option For Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2017)... , ... September 22, 2017 , ... Happy Living’s mission ... time - carries it into the entertaining and delicious worlds of theatre and ... (founder of Happy Living) convinced him to turn his play into a book. The ...
(Date:9/22/2017)... ... 22, 2017 , ... TopConsumerReviews.com recently awarded their highest five-star ... promote pancreatic health and regulate blood sugar levels . , Preventing diabetes ... negative side effects, and with the changes in today’s healthcare industry, not everyone ...
(Date:9/22/2017)... ... 22, 2017 , ... Silicon Valley startup Enke Life has ... Their electric toothbrushes aggressively attack oral bacteria by reducing dental plaque and other ... edge Enke technology with a premium timeless design, they want to redefine the ...
(Date:9/22/2017)... ... September 22, 2017 , ... The freshly released ... doorstep. According to Smart Mart, customers can now order vegetable, fruit, snacks, dairy, ... customers can find clothing at discounted prices. Apart from this, Smart Mart has ...
(Date:9/21/2017)... Viejo, CA (PRWEB) , ... September 21, 2017 , ... ... been so fun and easy to do. Users can select from up to two ... all with a click of a mouse all within Final Cut Pro X. ...
Breaking Medicine News(10 mins):
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform ... leadership team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 ... performance ratings for global supply chains, has published the first annual edition ... CSR performance of more than 20,400 companies evaluated by EcoVadis, based on ... 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
(Date:9/9/2017)... , Sept. 9, 2017  Eli Lilly and ... primary and secondary endpoint data for lasmiditan, an investigational, ... which demonstrated statistically significant improvements compared to placebo in ... highlighted today at the 18th Congress of the International ... "The data presented today demonstrate lasmiditan,s potential ...
Breaking Medicine Technology: